Omega-3 Fatty Acids (EPA/DHA) 用于 Autoimmune Conditions
BThe VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'immunecited.com';
const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dautoimmune\u002Dconditions';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
结论
The VITAL trial showed a 15% reduction in autoimmune disease risk with omega-3 supplementation. Additional clinical trials demonstrate benefits for supporting balanced inflammatory responses in rheumatoid arthritis and inflammatory bowel disease.
Key Study Findings
Review
Impact of Nutritional Diet Therapy on Rheumatoid Arthritis Disease Activity.
Dose: None
vs: None
Outcome: rheumatoid arthritis disease activity modulation through diet
效果: None
None
研究人群: patients with rheumatoid arthritis
Case Reports
n=1
GPIHBP1 Autoantibody-Related Hypertriglyceridemia in a 12-Year-Old Girl With Systemic Lupus Erythematosus.
Dose: None
vs: None
Outcome: GPIHBP1 autoantibody and LPL mass normalization
效果: None
None
研究人群: 12-year-old girl with SLE and severe hypertriglyceridemia
Review
Epigenetic and Mitochondrial Metabolic Dysfunction in Multiple Sclerosis: A Review of Herbal Drug Approaches and …
Dose: None
vs: None
Outcome: Epigenetic and mitochondrial modulation in MS
效果: None
None
研究人群: Multiple sclerosis patients (review)
Review
The Role of Nutrition in the Development, Management, and Prevention of Rheumatoid Arthritis: A Comprehensive …
Dose: None
vs: None
Outcome: RA risk and disease activity
效果: None
None
研究人群: Patients with rheumatoid arthritis
Review
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Dose: None
vs: None
Outcome: None
效果: None
None
研究人群: None
Systematic Review
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Dose: None
vs: None
Outcome: None
效果: None
None
研究人群: Systematic review of nutraceuticals in rheumatoid arthritis
Key Statistics
10
研究数量
25000
受试者
↑
Positive
B
等级
Referenced Papers
Case reports in …
2026
Nutrients
2026
Inflammopharmacology
2025
26 次引用
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Review
Autoimmunity reviews
2025
10 次引用
Molecular neurobiology
2025
6 次引用
Modulating inflammation and oxidative stress in rheumatoid arthritis: a systematic review of nutraceutical interventions.
Systematic Review
Inflammopharmacology
2025
1 次引用
Nutrients
2025
Critical reviews in …
2024
25 次引用
Autoimmunity reviews
2024
12 次引用
The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study.
Systematic Review
Nutrients
2024
2 次引用
European review for …
2023
67 次引用
Nutrients
2022
29 次引用
BMJ (Clinical research …
2022
9 次引用
Journal of medicinal …
2022
8 次引用
Nederlands tijdschrift voor …
2022
1 次引用
Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review.
Systematic Review
Nutritional neuroscience
2021
82 次引用
Clinical science (London, …
2021
35 次引用
Microbiology and immunology
2020
8 次引用
Current rheumatology reviews
2019
40 次引用
FEBS open bio
2016
1 次引用
Environmental health perspectives
2015
72 次引用
Medical hypotheses
2014
36 次引用
Current diabetes reports
2010
33 次引用
Journal of the …
2010
11 次引用
Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by N-3 fatty acids.
Other
Journal of the …
2005
64 次引用
Current opinion in …
2005
26 次引用
Current atherosclerosis reports
2004
464 次引用
Journal of the …
2002
2016 次引用
Age
1998
4 次引用
Biochemical Society transactions
1995
15 次引用
Journal of immunology …
1994
119 次引用
World review of …
1994
8 次引用
The American journal …
1991
2278 次引用
Rheumatic diseases clinics …
1991
19 次引用
Proceedings of the …
1990
49 次引用
The American journal …
1987
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 250-500 mg combined EPA/DHA/day
- antiinflammatory:
- 1,000-3,000 mg combined EPA/DHA/day
上限： 3,000 mg/day EPA+DHA (FDA-recognized as safe)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | 1 |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Neutral | -- |
最佳服用时间： With meals
Safety & Side Effects
已报告的副作用
- ⚠ Fishy aftertaste and burping
- ⚠ Gastrointestinal discomfort (nausea, diarrhea)
- ⚠ Increased bleeding risk at high doses
- ⚠ Potential LDL cholesterol increase at very high doses
已知相互作用
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk)
- ● Blood pressure medications (additive blood pressure lowering)
- ● Orlistat (may reduce omega-3 absorption)
- ● Cyclosporine (may modify immunosuppressive effects)
可耐受最高摄入量： 3,000 mg/day EPA+DHA (FDA-recognized as safe)
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Omega-3 Fatty Acids (EPA/DHA) help with Autoimmune Conditions?
Based on 10 studies with 25,000 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (EPA/DHA) may support Autoimmune Conditions management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Autoimmune Conditions?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Autoimmune Conditions?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 25,000 total participants. The overall direction of effect is positive.
Related Evidence
其他成分用于 Autoimmune Conditions
Omega-3 Fatty Acids (EPA/DHA) 用于其他健康状况
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。